Your session is about to expire
← Back to Search
Clairity for Mental Health Issue (FECU Trial)
N/A
Waitlist Available
Research Sponsored by Clarigent Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights
FECU Trial Summary
This trial is testing a new tool to help university students with mental health problems.
Eligible Conditions
- Mental Health Issue
- Suicide
- Depression
- Anxiety
FECU Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clairity Dashboard
Clinical Utility Treatment Outcomes
Identify Mental States with Area Under the AUC metric
+1 moreFECU Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Participants will complete a Clairity session between their regular therapy visits. The Clairity interview is between 4-11 minutes where a clinical research coordinator will ask participants questions about hope, secrets, anger, fear, and emotional pain.
Group II: ControlActive Control1 Intervention
Participants will submit demographics and medical records and will only complete standard of care.
Find a Location
Who is running the clinical trial?
Xavier UniversityUNKNOWN
Clarigent HealthLead Sponsor
2 Previous Clinical Trials
2,022 Total Patients Enrolled
Xavier University of Louisiana.OTHER
6 Previous Clinical Trials
2,728 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can speak and understand English well.You have an intellectual or neurocognitive disability that the study staff thinks may prevent you from participating.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies remaining in this medical experiment?
"Clinicaltrials.gov states that this clinical trial is presently not recruiting participants, despite being initially announced on November 4th 2021 and last updated on August 23rd 2022. Despite this specific study's state of repose, there are 1521 other medical trials seeking to enroll candidates at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger